Charles River Laboratories International Inc (CRL) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 27 2026 to Jun 28 2025 - CSIMarket
CSIMarket
 


Charles River Laboratories International inc   (NYSE: CRL)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare


Charles River Laboratories International Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Charles River Laboratories International Inc 's ROA in the second quarter of 2026?
Charles River Laboratories International Inc recorded a cumulative net loss of $-236 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -3.1%.

However, within the Healthcare sector 242 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 27 2026 quarter, so far to 2805, from total ROA ranking in the first quarter of 2026 at 3191.

What is ROA?



Return On Assets (Jun 27 2026)
II. Quarter
(Mar 28 2026)
I. Quarter
(Dec 27 2025)
IV. Quarter
(Sep 27 2025)
III. Quarter
(Jun 28 2025)
II. Quarter
Y / Y Total Assets Change 2.7 % 5.37 % -1.94 % -6.16 % -5.03 %
Y / Y Net Income Change - - - -20.97 % -44.1 %
Net Income (TTM) in million -236 -183 -142 -80 -65
Return On Assets (TTM) -3.1 % -2.42 % -1.9 % -1.06 % -0.85 %
CRL's Total Ranking # 2805 # 3191 # 2716 # 2707 # 2625
Total Assets (TTM) in million 7,719 7,940 7,342 7,478 7,516
Seq. Total Assets Change -2.78 % 8.14 % -1.81 % -0.5 % -0.26 %
Seq. Net Income Change - - - 5.43 % 103.62 %



Return On Assets Company Ranking
Within: No.
Industry # 15
Sector # 243
Overall # 2833

Return On Assets Statistics
High Average Low
7.73 %
3.77 %
-16 %
(Mar 26 2016)   (Jun 25 2011)





Financial Statements
Charles River Laboratories International Inc 's Assets $ 7,719 million CRL's Balance sheet
Charles River Laboratories International Inc 's Income $ -1 million Quarterly CRL's Income Statement
CRL's Income by Division See CRL's Income by Division



Annual Return On Assets (Dec 27 2025)
FY 2025
(Dec 28 2024)
FY 2024
(Dec 30 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 25 2021)
FY 2021
Y / Y Total Assets Change -1.94 % -8.2 % 7.85 % 8.27 % 28.07 %
Total Assets in million 7,342 7,487 8,157 7,563 6,985
Y / Y Net Income Change - -94.74 % -2.48 % 23.51 % 9.18 %
Net Income in million -142 25 480 493 399
Annual Return On Assets -1.94 % 0.34 % 5.89 % 6.51 % 5.71 %




More Return On Assets Ratios
CRL's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CRL's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CRL's Competitors
Subscribers only: Roa for Charles River Laboratories International Inc 's Suppliers
Subscribers only: Return On Assets for CRL's Customers

You may also want to know
CRL's Roi CRL's Inventory Turnover Ratio CRL's Growth Rates CRL's Dividend Comparisons
CRL's Profitability Ratios CRL's Asset Turnover Ratio CRL's Dividend Growth
CRL's Roe CRL's Valuation Ratios CRL's Financial Strength Ratios CRL's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 27 2026, within Healthcare Sector ROA


Date modified: 2026-09-01T19:51:46+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.